Paul‐André Bryon
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 12
- Genetics 4
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- Bertrand CoiffierPascale FelmanFrançoise BergerMartine FfrenchY BastionEvelyne Callet‐BauchuCatherine ThiéblemontGilles Salles
- Journals
- Annals of Oncology (2 papers)Cancer (1 paper)British Journal of Haematology (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Human Pathology (1 paper)
- Partner nations
- France
In The Last Decade
Paul‐André Bryon
18 papers receiving 669 citations
Peers
Comparison fields: 5 of 47
- Pathology and Forensic Medicine 509
- Genetics 265
- Oncology 338
- Neurology 150
- Hematology 85
Countries citing papers authored by Paul‐André Bryon
This map shows the geographic impact of Paul‐André Bryon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul‐André Bryon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul‐André Bryon more than expected).
Fields of papers citing papers by Paul‐André Bryon
This network shows the impact of papers produced by Paul‐André Bryon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul‐André Bryon. The network helps show where Paul‐André Bryon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul‐André Bryon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 48 | |
| 2 | 2005 | 4 | |
| 3 | 2003 | 5 | |
| 4 | 2000 | 214 | |
| 5 | 1996 | 20 | |
| 6 | 1995 | 19 | |
| 7 | 1994 | 20 | |
| 8 | 1991 | 3 | |
| 9 | 1991 | 91 | |
| 10 | 1991 | 17 | |
| 11 | 1991 | 63 | |
| 12 | 1990 | 15 | |
| 13 | 1990 | 52 | |
| 14 | 1989 | 24 | |
| 15 | 1987 | 30 | |
| 16 | 1987 | 27 | |
| 17 | 1981 | 27 | |
| 18 | 1981 | 8 |
About Paul‐André Bryon
Paul‐André Bryon is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Hematology and Reproductive Medicine, having authored 18 papers that have together received 687 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (12 papers), Viral-associated cancers and disorders (8 papers), Chronic Lymphocytic Leukemia Research (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Acute Myeloid Leukemia Research (2 papers), Eosinophilic Disorders and Syndromes (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (509 citations), Genetics (265 citations), Oncology (338 citations), Neurology (150 citations) and Hematology (85 citations). Paul‐André Bryon has collaborated with scholars based in France. Frequent co-authors include Bertrand Coiffier, Pascale Felman, Françoise Berger, Martine Ffrench, Y Bastion, Evelyne Callet‐Bauchu, Catherine Thiéblemont, Gilles Salles, Lucille Baseggio and Jean‐Pierre Magaud. Their work appears in journals such as Annals of Oncology, Cancer, British Journal of Haematology, JNCI Journal of the National Cancer Institute and Human Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.